Nasal cell collection to build a biobank for testing aerosol drugs
Official title: Collection of Primary Human Nasal Epithelial Cells
Run by University Hospital, Tours · NCT06407102 · Data updated 2026-11-12
Researchers will collect nasal cells during planned surgery to create a biobank and test aerosol drug delivery using air-liquid interface cultures.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital, Tours Academic / other |
| Locations | 1 site (Tours) |
| Status | Recruiting |
| Started | December 6, 2024 |
| Main results expected | May 2, 2027 |
| Study ends | May 2, 2028 |
| Registry record updated | June 16, 2026 |
| Trial ID | NCT06407102 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 who speak French, are affiliated with the French social security system, can consent in writing, and are scheduled for rhinologic surgery.
✕Probably not a fit
Participants whose tissue would not contribute to the biobank or who do not undergo usable nasal epithelial sampling may not directly benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project collects primary nasal epithelial cells from adults undergoing rhinologic surgery and grows them at the air–liquid interface to form a physiologic ex vivo model. The aim is to build a biobank of at least 60 samples and use these cells to study infection, inflammation, and potential aerosol therapies. This approach provides a human-relevant model that can reduce reliance on animal studies and help screen future aerosol drugs. The work focuses on maximizing cell yield, characterization, and context-specific testing conditions.
Why it matters
Potential benefit: If successful, the biobank could accelerate testing of inhaled therapies and improve understanding of nasal biology relevant to infections and inflammation.
How similar studies have gone: Previous work using nasal epithelial cells at the air–liquid interface has shown that such models can reflect airway biology and support drug testing, but commercial/biobank scale is still evolving.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (age \> 18 years) whose native language is French, or who understands French. * Affiliation with a French social security system (CMU accepted). * Informed consent, written and signed by the participant. * Planned rhinological surgery (meatotomy, septoplasty or turbinoplasty for example, but other surgeries as well) Exclusion Criteria: * Patients under court protection, guardianship or curatorship. * Pregnant or breast-feeding women (positive pregnancy test for women of childbearing age). * Patients presenting a major alteration of the mucosa or a malignant rhinosinus pathology.
Where it's running
-
Aussedat
Tours, France Recruiting
Study contacts
- Study coordinator: Charles Aussedat, MD
- Email: c.aussedat@chu-tours.fr
- Phone: 0247474747
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using dexmedetomidine to reduce agitation after nasal surgery
This study is testing whether giving a single dose of dexmedetomidine can help reduce agitation in obese adults after nasal surgery compared to a continuous drip of the medication.
-
Photodynamic therapy to prevent infections after nasal surgery
This study will test whether a preoperative nasal photodisinfection procedure lowers post‑operative infections and antibiotic use in people having elective nasal or sinus surgery.
-
Understanding how sensory brain signals vary in people with and without neurodevelopmental disorders
This study tests whether people with neurodevelopmental disorders show more variation in brain responses to sensory stimulation than people without these disorders.
-
Multiomics (genome plus metabolome) approach for adults with phenylketonuria
This project will test whether combining whole-genome sequencing from saliva and non-targeted blood metabolomics can find genetic and metabolic patterns linked to symptoms in adults who were treated for phenylketonuria from birth.
-
Improving prognosis after spontaneous intracerebral hemorrhage using clinical, blood, and imaging markers
This project will try combining clinical data, blood samples, and brain scans to find markers that predict outcomes for adults admitted with spontaneous intracerebral hemorrhage.
-
Communication support for ventilated intensive care patients
This project will try an eye-tracking tablet (JIB-Tours care) to help conscious, ventilated adults in ICU who cannot speak communicate with caregivers and family.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.